Majority of diseases mankind is suffering todays is because of gaining weight or obesity. The number of people suffering from obesity is due to various factors like sedentary lifestyle, and overeating of junk food. Weight gain results in several major health issues like cardiovascular diseases, strains on joints and abilities to perform daily tasks. Gaining weight results is rise of cholesterol and lipids. Lipids basically are a broad group of molecules that occur naturally in a one’s body and are inclusive of fats, sterols, and vitamins like vitamins A, D, E and K that are fat-soluble, monoglycerides, waxes, diglycerides, phospholipids, and others. The primary job of lipids is to conserve or store energy, give signals, and act just like structural components of cell membranes. Several industries are using lipids for various purposes. Lipids are being rampantly used by the cosmetic and food industries in nanotechnology. Also the healthcare sector is using lipids to resolve multiple health-related issues. Lipid-lowering therapy is one major treatment that is used extensively to reduce the risk of atherosclerotic cardiovascular disease (ASCVD), through statins. The global lipid-lowering therapy market is seeing excellent growth due to multiple factors.
Get PDF sample report with related graphs & charts (Pre & post COVID-19 impact analysis): https://www.absolutemarketsinsights.com/request_sample.php?id=1302
The growth of the global lipid-lowering therapy market was largely unaffected in the times of the COVID-19 pandemic. On contrary, the amount of revenue generated by this market skyrocketed. Lipid metabolism plays an important role when it comes to viral infections. The demand for lipid-lowering drugs just like NPC1L1 inhibitior, HMGCR inhibitiors, and PCSK9 inhibitiors were used extensively. One of the biggest factors that has been rapidly contributing to the growth of the global lipid-lowering therapy market is high demand for lipid-lowering medications due to increasing population that is suffering from obesity.
Meanwhile, concerns related to side effects of these drugs are likely to play restraining factor for the growth of the global lipid-lowering therapy market. Lipid-lowering drugs face regulatory challenges in couple of countries. On the other hand, the global lipid-lowering therapy market is forecasted to witness growth at an excellent rate due to use of lipids in nanotechnology by cosmetic and food industries.
The global lipid-lowering therapy market is forecasted to grow at a CAGR of 15.4% over the forecast period (2022 – 2030).
Speak to our analyst in case of queries before buying this report: https://www.absolutemarketsinsights.com/enquiry_before_buying.php?id=1302
By Drug Type, Statins Segment will Witness Fastest Growth for the Global Lipid-Lowering Therapy Market in 2022
Statins are a class of lipid-lowering medications that help in bringing down the illness and mortality in patients that are under high risk of cardiovascular disease. Statins are the most commonly used in medications to bring down the levels of the cholesterol.
Europe Region to witness fastest growth for this market Over the Forecast Period (2022 – 2030) in the Global Lipid-Lowering Therapy Market
Majority of population in countries like England, Germany and France, especially youngsters are suffering from obesity in wake of various factors like non-active lifestyle, consumption of junk or less nutritious food and hectic working conditions. All these factors are the reasons why this region will continue to dominate.
View our exclusive press releases on Industry Global News24
Some of the major players operating in the global lipid-lowering therapy market are listed below:
- Akums Drugs & Pharmaceuticals Ltd
- Alnylam Pharmaceuticals
- Amgen Inc.
- Merck & Co
- Novartis AG
- Regeneron Pharmaceuticals Inc.
- Sun Pharmaceutical Industries
- Other Market Participants
Purchase the latest in-depth Global Lipid-Lowering Therapy Market Report @ https://www.absolutemarketsinsights.com/checkout?id=1302
Global Lipid-Lowering Therapy Market Segmentation
Global lipid-lowering therapy market has been segmented by drug type, route of administration, age group and regions which are further classified into respective countries:
Global Lipid-Lowering Therapy Market Drug Type Outlook (Revenue, USD Million, 2015 - 2030)
- Atorvastatin (Lipitor)
- Cerivastatin (Baycol)
- Fluvastatin (Lescol)
- Lovastatin (Mevacor)
- Pravastatin (Pravachol)
- Simvastatin (Zocor)
- Bile acid sequestrants
- Icosapent ethyl
- Bempedoic acid
- PCSK9 Inhibitors
Global Lipid-Lowering Therapy Market Route of Administration Type Outlook (Revenue, USD Million, 2015 - 2030)
Global Lipid-Lowering Therapy Market Age Group Type Outlook (Revenue, USD Million, 2015 - 2030)
- 55 years or younger
- 56 – 60 years
- 61 – 65 years
- 66 – 70 years
- 71 – 75 years
- Older than 75 years
Global Lipid-Lowering Therapy Market Regional Outlook (Revenue, USD Million, 2015 - 2030)
- North America (U.S., Canada, Mexico, Rest of North America)
- Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe
- Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific
- Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
- Latin America (Brazil, Argentina, Rest of Latin America)
Request for customization to meet your precise research requirements: https://www.absolutemarketsinsights.com/request_for_customization.php?id=1302
Point Of Care (PoC) Lipid Test Market - https://www.absolutemarketsinsights.com/reports/Point-of-Care-PoC-Lipid-Test-Market-2022-2029-1082
Exosomes Market - https://www.absolutemarketsinsights.com/reports/Exosomes-Market-2019-2027-517
Absolute Markets Insights assists in providing accurate and latest trends related to consumer demand, consumer behavior, sales, and growth opportunities, for the better understanding of the market, thus helping in product designing, featuring, and demanding forecasts. Our experts provide you the end-products that can provide transparency, actionable data, cross-channel deployment program, performance, accurate testing capabilities and the ability to promote ongoing optimization. From the in-depth analysis and segregation, we serve our clients to fulfill their immediate as well as ongoing research requirements. Minute analysis impact large decisions and thereby the source of business intelligence (BI) plays an important role, which keeps us upgraded with current and upcoming market scenarios.
Contact Name: Shreyas Tanna
Company: Absolute Markets Insights
Email Id: [email protected]
Phone: IN +91-7400-24-24-24, US +1-510-420-1213